Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation — Stella

Home/Spinal Cord Injuries (SCI)/Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation

View on ClinicalTrials.gov

Recruiting

Back to Spinal Cord Injuries (SCI) trials

Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Medstar National Rehabilitation Hospital, Washington D.C., District of Columbia

Key details

Phase

Very early testing

Sponsor

Medstar Health Research Institute

Collaborators

Loyola University

Enrollment target

~40 participants

Started

September 2025

Primary completion

March 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.